BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3409965)

  • 1. [3H]quaternised ICS 205-930 labels 5-HT3 receptor binding sites in rat brain.
    Watling KJ; Aspley S; Swain CJ; Saunders J
    Eur J Pharmacol; 1988 May; 149(3):397-8. PubMed ID: 3409965
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of 5-HT3 binding sites in rat spinal cord synaptosomal membranes.
    Glaum SR; Anderson EG
    Eur J Pharmacol; 1988 Nov; 156(2):287-90. PubMed ID: 3240771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the atypical neuroleptic clozapine with 5-HT3 receptors in the cerebral cortex and superior cervical ganglion of the rat.
    Watling KJ; Beer MS; Stanton JA; Newberry NR
    Eur J Pharmacol; 1990 Jul; 182(3):465-72. PubMed ID: 1977590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of p-chloroamphetamine on release of [3H]gamma-aminobutyric acid from slices of rat caudate-putamen.
    Meyer DK; Holland A; Lais A; Szabo B
    Eur J Pharmacol; 1991 Apr; 196(2):189-95. PubMed ID: 1651873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lymphocyte 5-HT3 receptor subtype and its implication in fish T-cell proliferation.
    Meyniel JP; Khan NA; Ferrière F; Deschaux P
    Immunol Lett; 1997 Mar; 55(3):151-60. PubMed ID: 9161881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion.
    Hoyer D; Waeber C; Karpf A; Neijt H; Palacios JM
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):396-402. PubMed ID: 2586633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands.
    Maksay G
    Neuropharmacology; 1998 Dec; 37(12):1633-41. PubMed ID: 9886686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The (S)-isomer of [3H]zacopride labels 5-HT3 receptors with high affinity in rat brain.
    Waeber C; Pinkus LM; Palacios JM
    Eur J Pharmacol; 1990 Jun; 181(3):283-7. PubMed ID: 2384135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiography of [3H]quipazine in rodent brain.
    Perry DC
    Eur J Pharmacol; 1990 Oct; 187(1):75-85. PubMed ID: 2272355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
    Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
    Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of 5-HT3 receptors in the rat brain using [3H]LY278584.
    Gehlert DR; Gackenheimer SL; Wong DT; Robertson DW
    Brain Res; 1991 Jul; 553(1):149-54. PubMed ID: 1933271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats.
    Giordano J; Rogers LV
    Eur J Pharmacol; 1989 Oct; 170(1-2):83-6. PubMed ID: 2612565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clozapine and other neuroleptics on binding of [3H]-Q ICS 205-930 to central 5-HT3 recognition sites.
    Watling KJ; Beer MS; Stanton JA
    Br J Pharmacol; 1989 Dec; 98 Suppl():813P. PubMed ID: 2575419
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning.
    Carboni E; Acquas E; Leone P; Perezzani L; Di Chiara G
    Eur J Pharmacol; 1988 Jun; 151(1):159-60. PubMed ID: 3416924
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of 5-HT3 receptor antagonists on the discriminative stimulus effects of amphetamine.
    Moser PC
    Eur J Pharmacol; 1992 Mar; 212(2-3):271-4. PubMed ID: 1534768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-HT3 receptor antagonists on binding and function of mouse and human GABAA receptors.
    Klein RL; Sanna E; McQuilkin SJ; Whiting PJ; Harris RA
    Eur J Pharmacol; 1994 Jul; 268(2):237-46. PubMed ID: 7957645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competitive interaction of agonists and antagonists with 5-HT3 recognition sites in membranes of neuroblastoma cells labelled with [3H]ICS 205-930.
    Hoyer D; Neijt HC; Karpf A
    J Recept Res; 1989; 9(1):65-79. PubMed ID: 2915346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that the atypical 5-HT3 receptor ligand, [3H]-BRL46470, labels additional 5-HT3 binding sites compared to [3H]-granisetron.
    Steward LJ; Ge J; Bentley KR; Barber PC; Hope AG; Lambert JJ; Peters JA; Blackburn TP; Barnes NM
    Br J Pharmacol; 1995 Sep; 116(2):1781-8. PubMed ID: 8528560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT3 receptor antagonists on 5-HT and nicotinic depolarizations in guinea-pig submucosal neurones.
    Vanner S; Surprenant A
    Br J Pharmacol; 1990 Apr; 99(4):840-4. PubMed ID: 2141798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.